The Effect of Bi-Terminal PEGylation of an Integrin α(v)β(6)–Targeted (18)F Peptide on Pharmacokinetics and Tumor Uptake

Similar Items

• The Effects of an Albumin Binding Moietyon the Targeting and Pharmacokinetics of an Integrin α(v)β(6)-Selective Peptide Labeledwith Aluminum [(18)F]Fluoride
  od: Hausner, Sven H., i dr.
  Izdano: (2020)
• In Vivo Imaging with an α(v)β(6) Specific Peptide Radiolabeled using (18)F-“Click” Chemistry: Evaluation and Comparison with the Corresponding 4-[(18)F]Fluorobenzoyl- and 2-[(18)F]Fluoropropionyl-Peptides
  od: Hausner, Sven H., i dr.
  Izdano: (2008)
• Preclinical development and first-in-human imaging of the integrin α(v)β(6) with [(18)F]α(v)β(6)-Binding Peptide in metastatic carcinoma.
  od: Hausner, Sven H., i dr.
  Izdano: (2018)
• Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
  od: Offman, Elliot, i dr.
  Izdano: (2016)
• Characterization and Evaluation of (64)Cu-Labeled A20FMDV2 Conjugates for Imaging the Integrin α(v)β(6)
  od: Hu, Lina Y., i dr.
  Izdano: (2014)